Fighting AMR & Superbugs in the Era of COVID-19

Explore Fast & Accurate PCR Results in ~1 Hour* for Improved Infection Control & Antimicrobial Stewardship
Download Infobrief

Antimicrobial resistance (AMR) is growing rapidly, with superbugs threatening our ability to treat common infectious diseases.

The COVID-19 pandemic has elevated concerns over AMR and antibiotic-associated adverse events, with surges in antibiotic prescribing, hospitalizations and drug-resistant bacterial transmissions.1,2

The threat on the front line today:

Increased Empirical Antibiotic Prescribing1
Increased Risk of C. difficile Rapidly Developing3
Increased Drug-resistant Outbreaks in COVID-19 ICUs2

Protect Patients & Fight AMR with Fast PCR in ~1 Hour*

Fast & accurate PCR with Cepheid’s GeneXpert® System greatly improves time to result, allowing healthcare professionals to quickly identify, isolate and appropriately manage colonized or infected patients, helping prevent spread.4,5

Explore fast, on-demand testing for a range of infectious diseases:

Time to Results

 

C. difficile

43
min
 

Carbapenem-resistant Bacteria

50
min
 

VRE

48
min
 

MRSA & S. aureus

47
min^
 

Multiple Drug-resistant TB

<90
min

Patient Pathway Impact

Cepheid’s on-demand testing solutions provide high-quality answers, anywhere and anytime your patients need care.‍

References

CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.
* Turnaround times vary by test. See individual Product Inserts for specific turnaround times.
^ For positive MRSA reporting. Reporting negatives in 70 minutes.
1. Langford B, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
2. Belvisi V, et al. Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) prevention and control program:convergent or divergent action? J Hosp Infect. 2020 Dec;109:29-31
3. Spigaglia P. COVID-19 and Clostridioides difficile infection (CDI): possible implications for elderly patients. Anaerobe. 2020 Aug;64:102233
4. Corless C, et al. Impact of different carbapenemase-producing Enterobacterales screening strategies in a hospital setting. IPIP. 2020 May;3(2):100011
5. Casari E, et al. Reducing rates of C. difficile infection by switching to a stand-alone NAAT with clear sampling criteria. Antimicrob Resist Infect Control. 2018 Mar;7(40)

Request Information
Download 2021 AMR Info-brief